NBL logo 2019 kicsi

NBL logo 2019 kicsi

National Biosafety Laboratory Hungary

First TransNational Access Call to ERINHA’s full catalogue of services, including access to cutting edge high containment facilities was launched today!

The call is funded under the EU H2020 ERINHA-Advance project.

The following pathogens are prioritized:

  • Ebola virus
  • Marburg virus
  • Lassa virus
  • Crimean Congo Hemorrhagic Fever virus
  • Nipah virus

Applications must fall into one of the following scientific topics:

SECTION 1: Innovative therapeutics, vaccines or diagnosis approaches for RG4 pathogens

  • Development of RG4 pathogens’ standards for diagnosis
  • Development of innovative technologies for diagnosis
  • Development of innovative alternatives for antibodies production for diagnosis and therapeutics purpose
  • Development of innovative therapeutics tools/ immunotherapy
  • Development of new synthetic methods to improve immunogenicity of vaccines
  • Development of new approach for the design of antiviral drugs
  • Development of vaccines against RG4 pathogens

SECTION 2: Innovative approaches to study highly infectious viruses in animal experimentation

  • Optimization/ adaptation of rodent models
  • Development of telemetry technics/ biochemistry technics for animal experimentation
  • Development and optimization of alternative technologies to animal models
  • Development of innovative real-time imaging capacity in BSL 4 conditions

Deadline for applications: 15 December 2019

For more information please check ERINHA-Advance TNA Programme TNA section .

© National Biosafety Laboratory
2020 Minden jog fenntartva!
Impresszum | Kapcsolat facebook twitter rss